Retinoic acid-binding protein in human breast cancer and dysplasia.
Seventy-five specimens of human breast tissue were checked for the presence of cellular retinoic acid-binding protein (cRABP). Fifty-two percent of the primary carcinomas and 43% of the dysplastic breast lesions (stage MII) contained detectable amounts of crabp, whereas no cRABP was found in normal tissue. Sucrose gradient centrifugation and electrophoresis on agarose were used for analysis of the presence of cRABP. The cRABP of human origin (normal uterus and neoplastic mammary tissue) differed in its mobility in agarose electrophoresis from that of rat testis cRABP.
D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000378:metabolism*; D011230:Precancerous Conditions / Q000378:metabolism*; D051381:Rats; D013737:Testis / Q000378:metabolism; D014212:Tretinoin / Q000378:metabolism*; D014599:Uterus / Q000378:metabolism; D014801:Vitamin A / Q000031:analogs & derivatives*
D002352:Carrier Proteins; D009363:Neoplasm Proteins; D014801:Vitamin A; D014212:Tretinoin